Portu, M., Sanz-Beltran, J., Pellicer, A., Navarro, B., Monleon, A. R., Capdevila, P., Tallafigo, F. L., Moran, T., Catot, S., Munoz, S. P., Arriola, E., Sanchez, A., Osorio, K., Muñoz, A., Isla, D., Guarner, B., Piedra, A., Recio, S. M., Barba, A., Majem, M. (2026). Prognostic factors and impact of concomitant medication in extensive-stage small cell lung cancer (ES-SCLC) treated with first-line chemotherapy plus anti-PD-L1: A Spanish multicenter real-world study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8107